ARTICLE IStock Purchase Agreement • July 9th, 1998 • Palatin Technologies Inc • In vitro & in vivo diagnostic substances • New York
PALATIN TECHNOLOGIES, INC. PURCHASE AGREEMENT TABLE OF CONTENTS 1. PURCHASE AND SALE OF SECURITIES.......................................1 1.1 Issue of Securities..........................................1 2. CLOSING DATE;...Purchase Agreement • September 30th, 2002 • Palatin Technologies Inc • Pharmaceutical preparations • New York
OFWarrant Agreement • February 2nd, 2001 • Palatin Technologies Inc • In vitro & in vivo diagnostic substances • New York
COMMON STOCK PURCHASE WARRANT PALATIN TECHNOLOGIES, Inc.Common Stock Purchase Warrant • November 2nd, 2022 • Palatin Technologies Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May 2, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Palatin Technologies, Inc., a Delaware corporation (the “Company”), up to ____________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 2nd, 2022 • Palatin Technologies Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of October 31, 2022, between Palatin Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PALATIN LOGO OMMITTED] -------------------------------------------------------- ------------------------ EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement"), made this 9th day of May, 2005 is entered into by Palatin Technologies, Inc., a...Employment Agreement • September 13th, 2005 • Palatin Technologies Inc • Pharmaceutical preparations • New Jersey
SERIES A COMMON STOCK PURCHASE WARRANT PALATIN TECHNOLOGIES, Inc.Security Agreement • June 21st, 2024 • Palatin Technologies Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Armistice Capital Master Fund Ltd., or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after June 24, 2024 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on June 24, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Palatin Technologies, Inc., a Delaware corporation (the “Company”), up to [•] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SEPARATION AGREEMENT AND GENERAL RELEASE BY THIS AGREEMENT YOU GIVE UP CERTAIN LEGAL RIGHTS. PLEASE CONSULT WITH AN ATTORNEY BEFORE YOU SIGN IT. AGREEMENT made as of November 30, 2000 by and between Charles Putnam ("Employee," "You" or "Your") and...Separation Agreement • February 14th, 2001 • Palatin Technologies Inc • In vitro & in vivo diagnostic substances • New Jersey
RECITALSPurchase Agreement • September 29th, 2003 • Palatin Technologies Inc • Pharmaceutical preparations • New York
PALATIN TECHNOLOGIES, INC. REGISTRATION RIGHTS AGREEMENT Table of ContentsRegistration Rights Agreement • December 10th, 2002 • Palatin Technologies Inc • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 1st, 2024 • Palatin Technologies Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 29, 2024, between Palatin Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
REGISTRATION RIGHTS AGREEMENT Table of ContentsRegistration Rights Agreement • September 30th, 2002 • Palatin Technologies Inc • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made and entered into as of April 28, 1998, among Palatin Technologies, Inc., a Delaware corporation (the "Company"), and the parties who have executed the...Registration Rights Agreement • May 8th, 1998 • Palatin Technologies Inc • In vitro & in vivo diagnostic substances • New York
EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement"), made this 9th day of October, 1998, is entered into by Palatin Technologies, Inc., a Delaware corporation with its principal place of business at 214 Carnegie Center, Suite 100,...Employment Agreement • November 16th, 1998 • Palatin Technologies Inc • In vitro & in vivo diagnostic substances • New Jersey
LEASE AND LEASE AGREEMENTLease Agreement • September 26th, 1997 • Palatin Technologies Inc • In vitro & in vivo diagnostic substances • New Jersey
EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement"), made this 1st day of October, 2003, is entered into by Palatin Technologies, Inc., a Delaware corporation with its principal place of business at 4C Cedar Brook Drive, Cranbury, NJ,...Employment Agreement • November 14th, 2003 • Palatin Technologies Inc • Pharmaceutical preparations • New Jersey
PRE-FUNDED COMMON STOCK PURCHASE WARRANT PALATIN TECHNOLOGIES, Inc.Warrant Agreement • November 2nd, 2022 • Palatin Technologies Inc • Pharmaceutical preparations
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Palatin Technologies, Inc., a Delaware corporation (the “Company”), up to ____________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PRE-FUNDED COMMON STOCK PURCHASE WARRANT PALATIN TECHNOLOGIES, INC.Pre-Funded Common Stock Purchase Warrant • October 24th, 2023 • Palatin Technologies Inc • Pharmaceutical preparations
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Palatin Technologies, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
BACKGROUNDMerger Agreement • November 30th, 1999 • Palatin Technologies Inc • In vitro & in vivo diagnostic substances • Delaware
BACKGROUNDRegistration Rights Agreement • September 29th, 2003 • Palatin Technologies Inc • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 1st, 2010 • Palatin Technologies Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February 24, 2010, between Palatin Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
COMMON STOCK PURCHASE WARRANT PALATIN TECHNOLOGIES, INC.Common Stock Purchase Warrant • May 16th, 2022 • Palatin Technologies Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the making of a Redemption Consideration Election (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May 11, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Palatin Technologies, Inc., a Delaware corporation (the “Company”), up to [ ] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made this 31st day of December, 1998, by PALATIN TECHNOLOGIES, INC., a Delaware corporation (the "Company"), for the benefit of each Purchaser (individually a...Registration Rights Agreement • February 16th, 1999 • Palatin Technologies Inc • In vitro & in vivo diagnostic substances • New York
COMMON STOCK PURCHASE WARRANT PALATIN TECHNOLOGIES, INC.Securities Agreement • June 28th, 2010 • Palatin Technologies Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time or times on or after the date hereof (the “Exercisability Date”), but not after 11:59 p.m., New York City time, on November 26, 2012 (the “Termination Date”), to subscribe for and purchase from Palatin Technologies, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock. This Warrant is issued by the Company as of the date hereof pursuant to (i) Section 1 of the Engagement Agreement, dated June 25, 2010, by and between the Company and Rodman & Renshaw, LLC and (ii) Section 4(2) of the Securities Act and Rule 506 promulgated thereunder.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 16th, 2022 • Palatin Technologies Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May 11, 2022, between Palatin Technologies, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser”).
REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (the "Agreement") is made and entered into as of July 8, 1998, by and between Palatin Technologies, Inc., a Delaware corporation (the "Company"), and TheraTech, Inc., a Delaware...Registration Rights Agreement • July 9th, 1998 • Palatin Technologies Inc • In vitro & in vivo diagnostic substances • New York
PALATIN LOGO] ----------------------------------------------------------------- --------------- EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement"), made this 1st day of October, 2005, is entered into by Palatin Technologies, Inc., a...Employment Agreement • November 8th, 2005 • Palatin Technologies Inc • Pharmaceutical preparations • New Jersey
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT PALATIN TECHNOLOGIES, Inc.Placement Agent Common Stock Purchase Warrant • November 2nd, 2022 • Palatin Technologies Inc • Pharmaceutical preparations
THIS Placement Agent COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on October 31, 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Palatin Technologies, Inc., a Delaware corporation (the “Company”), up to ____________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued by the Company pursuant to that certain engagement letter, dated as of October 18, 2022, by and between the Company and H.C. Wainwright & Co., LLC.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 24th, 2023 • Palatin Technologies Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of October 20, 2023, between Palatin Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
CONFIDENTIALPlacement Agent Agreement • June 28th, 2010 • Palatin Technologies Inc • Pharmaceutical preparations • New York
COMMON STOCK PURCHASE WARRANT PALATIN TECHNOLOGIES, INC.Common Stock Purchase Warrant • June 28th, 2010 • Palatin Technologies Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time or times on or after the date hereof (the “Exercisability Date”), but not after 11:59 p.m., New York City time, on June ___, 2011 (the “Termination Date”), to subscribe for and purchase from Palatin Technologies, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock.
CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT PALATIN TECHNOLOGIES, INC. April 28, 1998 CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT, dated as of April 28, 1998 (this "Agreement"), between Palatin Technologies, Inc., a Delaware corporation (the...Convertible Preferred Stock Purchase Agreement • May 8th, 1998 • Palatin Technologies Inc • In vitro & in vivo diagnostic substances • New York
AMENDMENT TO EMPLOYMENT AGREEMENT This Amendment to that certain Employment Agreement dated as of November 16, 1995 (the "Employment Agreement") between RhoMed Incorporated, a Delaware corporation ("RhoMed"), and Edward J. Quilty, an individual...Employment Agreement • September 26th, 1997 • Palatin Technologies Inc • In vitro & in vivo diagnostic substances
ContractWarrant Agreement • July 7th, 2015 • Palatin Technologies Inc • Pharmaceutical preparations • Delaware
THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO OR AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED.
PALATIN TECHNOLOGIES, INC. PURCHASE AGREEMENT TABLE OF CONTENTSPurchase Agreement • December 10th, 2002 • Palatin Technologies Inc • Pharmaceutical preparations • New York
